189 related articles for article (PubMed ID: 35254413)
1. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
[TBL] [Abstract][Full Text] [Related]
2. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
[TBL] [Abstract][Full Text] [Related]
3. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
4. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer.
Siraj AK; Bu R; Masoodi T; Parvathareddy SK; Iqbal K; Al-Haqawi W; Al-Dossari H; Azam S; Qadri Z; Annaiyappanaidu P; Al-Dayel F; Al-Kuraya KS
Sci Rep; 2022 Jul; 12(1):13098. PubMed ID: 35907983
[TBL] [Abstract][Full Text] [Related]
6. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.
Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H
Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230
[TBL] [Abstract][Full Text] [Related]
7. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
8. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF
Elez E; Ros J; Fernández J; Villacampa G; Moreno-Cárdenas AB; Arenillas C; Bernatowicz K; Comas R; Li S; Kodack DP; Fasani R; Garcia A; Gonzalo-Ruiz J; Piris-Gimenez A; Nuciforo P; Kerr G; Intini R; Montagna A; Germani MM; Randon G; Vivancos A; Smits R; Graus D; Perez-Lopez R; Cremolini C; Lonardi S; Pietrantonio F; Dienstmann R; Tabernero J; Toledo RA
Nat Med; 2022 Oct; 28(10):2162-2170. PubMed ID: 36097219
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
Wang J; Li R; Li J; Yi Y; Liu X; Chen J; Zhang H; Lu J; Li C; Wu H; Liang Z
J Transl Med; 2021 Oct; 19(1):433. PubMed ID: 34657620
[TBL] [Abstract][Full Text] [Related]
10. Predictive Impact of
Moretto R; Germani MM; Ros J; Daniel F; Ghelardi F; Vetere G; Giordano M; Toledo RA; Bergamo F; Randon G; Elez E; Lonardi S; Pietrantonio F; Vignali P; Rossini D; Matito J; Ugolini C; Fontanini G; Masi G; Cremolini C
JCO Precis Oncol; 2023 Sep; 7():e2300255. PubMed ID: 37797285
[TBL] [Abstract][Full Text] [Related]
11. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
12. Association of RNF43 Genetic Alterations With BRAF
Vogel A; Murugesan K; Kendre G; Quintanilha JCF; Ross JS; Brummer T; Saborowski A
JCO Precis Oncol; 2024 Feb; 8():e2300411. PubMed ID: 38394466
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer.
Quintanilha JCF; Graf RP; Oxnard GR
Oncologist; 2023 Mar; 28(3):e171-e174. PubMed ID: 36779536
[TBL] [Abstract][Full Text] [Related]
14. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
[TBL] [Abstract][Full Text] [Related]
15. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cocco E; Benhamida J; Middha S; Zehir A; Mullaney K; Shia J; Yaeger R; Zhang L; Wong D; Villafania L; Nafa K; Scaltriti M; Drilon A; Saltz L; Schram AM; Stadler ZK; Hyman DM; Benayed R; Ladanyi M; Hechtman JF
Cancer Res; 2019 Mar; 79(6):1047-1053. PubMed ID: 30643016
[TBL] [Abstract][Full Text] [Related]
17. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
[TBL] [Abstract][Full Text] [Related]
18. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and molecular correlations in traditional serrated adenoma.
Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
[TBL] [Abstract][Full Text] [Related]
20. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
